Prospectus

MADRIGAL PHARMACEUTICALS, INC. Filed 2022-12-23 Acc 0001193125-22-311541

Documents 1

2023-05-09 424B5 Prospectus
2022-12-28 4 SVP and General Counsel sold 7,000 shares at an average $274.18 ($1,919,231)
2022-12-28 4 Chief Commercial Officer sold 30,000 shares at an average $274.14 ($8,224,073)
2022-12-23 424B5 Prospectus
2022-12-23 8-K Material agreement · Bylaws or fiscal year change · Regulation FD disclosure · Other events
2022-12-19 8-K Regulation FD disclosure · Other events
2021-06-01 424B5 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading d398607d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…